ORTHO ORGANIZERS TEMPORARY ORTHODONTIC ANCHOR
Device Facts
| Record ID | K061266 |
|---|---|
| Device Name | ORTHO ORGANIZERS TEMPORARY ORTHODONTIC ANCHOR |
| Applicant | Ortho Organizers, Inc. |
| Product Code | OAT · Dental |
| Decision Date | Jul 31, 2006 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 872.3640 |
| Device Class | Class 2 |
| Attributes | Therapeutic |
Indications for Use
The Ortho Organizers Temporary Orthodontic Anchor is intended to provide a fixed anchorage point for attachment of orthodontic appliances to facilitate the orthodonic movement of teeth.
Device Story
Temporary orthodontic anchor; single-piece titanium alloy implant; threaded shaft for bone anchorage; low-profile proximal head with undercut and transverse circular opening for appliance attachment; vertical flats for tool-assisted implantation. Used in dental clinic by orthodontists; implanted into alveolar ridge. Provides stable anchorage for orthodontic appliances; facilitates tooth movement; benefits patient by enabling controlled orthodontic treatment.
Clinical Evidence
Bench testing only; no clinical data provided.
Technological Characteristics
Material: Ti-6Al-4V ELI titanium alloy (ASTM F136). Design: Single-piece, threaded shaft, tapered conical section, proximal head with attachment points. Energy: None (mechanical). Connectivity: None. Sterilization: Non-sterile, intended for sterilization prior to use.
Indications for Use
Indicated for patients requiring fixed anchorage points for orthodontic appliances to facilitate tooth movement.
Regulatory Classification
Identification
An endosseous dental implant is a prescription device made of a material such as titanium or titanium alloy that is intended to be surgically placed in the bone of the upper or lower jaw arches to provide support for prosthetic devices, such as artificial teeth, in order to restore a patient's chewing function.
Special Controls
*Classification.* (1) Class II (special controls). The device is classified as class II if it is a root-form endosseous dental implant. The root-form endosseous dental implant is characterized by four geometrically distinct types: Basket, screw, solid cylinder, and hollow cylinder. The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)(2) *Classification.* Class II (special controls). The device is classified as class II if it is a blade-form endosseous dental implant. The special controls for this device are:(i) The design characteristics of the device must ensure that the geometry and material composition are consistent with the intended use; (ii) Mechanical performance (fatigue) testing under simulated physiological conditions to demonstrate maximum load (endurance limit) when the device is subjected to compressive and shear loads; (iii) Corrosion testing under simulated physiological conditions to demonstrate corrosion potential of each metal or alloy, couple potential for an assembled dissimilar metal implant system, and corrosion rate for an assembled dissimilar metal implant system; (iv) The device must be demonstrated to be biocompatible; (v) Sterility testing must demonstrate the sterility of the device; (vi) Performance testing to evaluate the compatibility of the device in a magnetic resonance (MR) environment; (vii) Labeling must include a clear description of the technological features, how the device should be used in patients, detailed surgical protocol and restoration procedures, relevant precautions and warnings based on the clinical use of the device, and qualifications and training requirements for device users including technicians and clinicians; (viii) Patient labeling must contain a description of how the device works, how the device is placed, how the patient needs to care for the implant, possible adverse events and how to report any complications; and (ix) Documented clinical experience must demonstrate safe and effective use and capture any adverse events observed during clinical use.